Relationship of Dickkopf1 (DKK1) with Cardiovascular Disease and Bone Metabolism in Caucasian Type 2 Diabetes Mellitus

PLoS ONE

Volumn 9, Issue 11, 2014, Pages

  Garcia Martín, Antonia ^a,b   Reyes Garcia, Rebeca ^a,c   García Fontana, Beatriz ^a   Morales Santana, Sonia ^a,d   Coto Montes, Ana ^e   Muñoz Garach, Manuel ^a   Rozas Moreno, Pedro ^f   Muñoz Torres, Manuel ^a  

^a HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

^b Hospital Comarcal del Noroeste   (Spain)

^c HOSPITAL GENERAL UNIVERSITARIO REINA SOFÍA   (Spain)

^d Fundacion Para la Investigacion Biosanitaria de Andalucia Oriental Alejandro Otero   (Spain)

^e UNIVERSITY OF OVIEDO   (Spain)

^f HOSPITAL GENERAL UNIVERSITARIO DE CIUDAD REAL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

DICKKOPF 1 PROTEIN; HEMOGLOBIN A1C; DKK1 PROTEIN, HUMAN; SIGNAL PEPTIDE;

ADULT; AREA UNDER THE CURVE; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; BODY MASS; BONE DENSITY; BONE METABOLISM; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CROSS-SECTIONAL STUDY; DISEASE MARKER; DYSLIPIDEMIA; FEMALE; GENDER; GLOMERULUS FILTRATION RATE; HUMAN; HUMAN CELL; HYPERTENSION; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; RISK FACTOR; SMOKING; BLOOD; COMPLICATION; METABOLISM; MIDDLE AGED;

BONE DENSITY; CARDIOVASCULAR DISEASES; CAROTID INTIMA-MEDIA THICKNESS; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED;

EID: 84921984449     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0111703     Document Type: Article

References (44)

1. Madonna R, De Caterina R (2011) Cellular and molecular mechanisms of vascular injury in diabetes-part I: Pathways of vascular disease in diabetes. Vascular Pharmacology 54: 68-74.
2. Magnus JH, Brussard DL (2005) Relationship between bone mineral density and myocardial infarction in US adults. Osteoporosis International 16: 2053-2062.
3. Hofbauer LC, Brueck CC, Singh SK, Dognig H (2007) Osteoporosis in patients with diabetes mellitus. Journal of Bone and Mineral Research 22: 1317-1328.
4. Epstein S, Leroith D (2008) Diabetes and fragility fractures - A burgeoning epidemic? Bone 43: 3-6.
5. Carr JJ, Register TC, Hsu FC, Lohman K, Lenchik L, et al. (2008) Calcified atherosclerotic plaque and bone mineral density in type 2 diabetes: The diabetes heart study. Bone 42: 43-52.
6. Divers J, Register TC, Langefeld CD, Wagenknecht LE, Bowden DW, et al. (2011) Relationships between calcified atherosclerotic plaque and bone mineral density in AAs with type 2 diabetes. Journal of Bone and Mineral Research 26: 1554-1560.
7. Gordon MD, Nusse R (2006) Wnt signalling: Multiple pathways, multiple receptors and multiple transcription factors. Journal of Biology and Chemistry 281: 22429-22433.
8. Huang H, He X (2008) Wnt/beta-catenin signaling: New (and old) players and new insight. Current Opinion in Cell Biology 20: 119-125.
9. Mao B, Wu W, Davidson G, Marhold J, Li M, et al. (2002) Kremen proteins are Dickkopf receptors that regulate Wnt/-catenin signalling. Nature 417: 664-667.
10. Shao JS, Cheng SL, Pingsterhaus JM, Charlton-Kachigian N, Loewy AP, et al. (2005) Msx2 promotes cardiovascular calcification by activating paracrine Wnt signals. Journal of Clinical Investigation 115: 1210-1220.
11. Sen M, Ghosh G (2008) Transcriptional outcome of Wnt-Frizzled signal transduction in inflammation: Evolving concepts. Journal of Immunology 181: 4441-4445.
12. Christman MA 2nd, Goetz DJ, Dickerson E, McCall KD, Lewis CJ, et al. (2008) Wnt5a is expressed in murine and human atherosclerotic lesions. American Journal of Physiology and Heart Circulation and Physiology 294: H2864-2870.
13. Cheng SL, Shao JS, Behrmann A, Krchma K, Towler DA (2013) Dkk1 and MSX2-Wnt7b signaling reciprocally regulate the endothelial-mesenchymal transition in aortic endothelial cells. Arterioscler Thromb Vasc Biol 33: 1679-89.
14. Krenning G, Zeisberg EM, Kalluri R (2010) The origin of fibroblasts and mechanism of cardiac fibrosis. J Cell Physiol 225: 631-637.
15. Wylie-Sears J, Aikawa E, Levine RA, Yang JH, Bischoff J (2011) Mitral valve endothelial cells with osteogenic differentiation potential. Arterioscler Thromb Vasc Biol 31: 598-607.
16. Fang Y, Ginsberg C, Seifert M, Agapova O, Sugatani T, et al. (2014) CKDInduced Wingless/Integration1 Inhibitors and Phosphorus Cause the CKDMineral and Bone Disorder. J Am Soc Nephrol 25: 1760-73.
17. Kim KI, Park KU, Chun EJ, Choi SI, Cho YS, et al. (2011) A novel biomarker of coronary atheroesclerosis: Serum DKK1 concentration correlates with coronary artery calcification and atherosclerotic plaques. Journal of Korean Medical Science 26: 1178-1184.
18. Register TC, Hruska KA, Divers J, Bowden DW, Palmer ND, et al. (2013) Plasma Dickkopf (DKK1) concentrations negatively associate with atherosclerotic calcified plaque in African-Americans with type 2 diabetes. Journal of Clinical Endocrinology and Metabolism 98: 60-65.
19. Butler JS, Murray DW, Hurson CJ, O'Brien J, Doran PP, et al. (2011) The role of Dkk1 in bone mass regulation: Correlating serum Dkk1 expression with bone mineral density. Journal of Orthopaedic Research 29: 414-418.
20. Polyzos SA, Anastasilakis AD, Bratengeier C, Woloszczuk W, Papatheodorou A, et al. (2012) Serum sclerostin levels positively correlate with lumbar spinal bone mineral density in postmenopausal women-the six-month effect of risedronate and teriparatide. Osteoporosis International 23: 1171-1176.
21. Cejka D, Jäger-Lansky A, Kieweg H, Weber M, Bieglmayer C, et al. (2012) Sclerostin serum levels correlate positively with bone mineral density and microarchitecture in haemodialysis patients. Nephrology Dialysis Transplantion 27: 226-230.
22. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, et al. (2009) CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate. Ann Intern Med 150: 604-612.
23. McCloskey EV, Spector TD, Eyres KS, Fern ED, O'Rourke N, et al. (1993) The assessment of vertebral deformity: A method for use in population studies and clinical trials. Osteoporosis International 3: 138-147.
24. Junyent M, Gilabert R, Nun?ez I, Corbella E, Vela M, et al. (2005) Carotid ultrasound in the assessment of preclinical atherosclerosis. Distribution of intimamedia thickness values and plaque frequency in a Spanish community cohort. Medicina Clinica 125: 770-774.
25. Seifert-Held T, Pekar T, Gattringer T, Simmet NE, Scharnagl H, et al. (2011) Circulating Dickkopf-1 in acute ischemic stroke and clinically stable cerebrovascular disease. Atherosclerosis 218: 233-237.
26. Ueland T, Otterdal K, Lekva T, Halvorsen B, Gabrielsen A, et al. (2009) Dickkopf-1 enhances inflammatory interaction between platelets and endothelial cells and shows increased expression in atherosclerosis. Arteriosclerosis Thrombosis and Vascular Biology 29: 1228-1234.
27. Mill C, George SJ (2012) Wnt signalling in smooth muscle cells and its role in cardiovascular disorders. Cardiovascular Research 95: 233-40.
28. Bild DE, Detrano R, Peterson D, Guerci A, Liu K, et al. (2005) Ethnic differences in coronary calcification: The Multi-Ethnic Study of Atherosclerosis (MESA). Circulation 111: 1313-20.
29. Lee TC, O'Malley PG, Feuerstein I, Taylor AJ (2003) The prevalence and severity of coronary artery calcification on coronary artery computed tomography in black and white subjects. J Am Coll Cardiol 41: 39-44.
30. Freedman BI, Hsu FC, Langefeld CD, Rich SS, Herrington DM, et al. (2005) The impact of ethnicity and sex on subclinical cardiovascular disease: The Diabetes Heart Study. Diabetologia 48: 2511-8.
31. Wade AN, Fedyna S, Mehta NN, St. Clair C, Ginwala N, et al. (2011) Type 2 diabetes does not attenuate racial differences in coronary calcification. Diabetes Res Clin Pract 91: 101-7.
32. Divers J, Palmer ND, Lu L, Register TC, Carr JJ, et al. (2013) Admixture mapping of coronary artery calcified plaque in African Americans with type 2 diabetes mellitus. Circ Cardiovasc Genet; 6: 97-105.
33. Karter AJ, Ferrara A, Liu JY, Moffet HH, Ackerson LM, et al. (2002) Ethnic disparities in diabetic complications in an insured population. JAMA 287: 2519-27.
34. Young BA, Maynard C, Boyko EJ (2003) Racial differences in diabetic nephropathy, cardiovascular disease, and mortality in a national population of veterans. Diabetes Care 26: 2392-9.
35. Freedman BI, Hsu FC, Langefeld CD, Rich SS, Herrington DM, et al. (2005) The impact of ethnicity and sex on subclinical cardiovascular disease: The Diabetes Heart Study. Diabetologia 48: 2511-8.
36. Cannata-Andia JB, Roman-Garcia P, Hruska K (2011) The connections between vascular calcification and bone health. Nephrol Dial Transplant 26: 3429-36.
37. Bell NH, Williamson B, Hollis B, Riggs BL (2001) Effects of race on diurnal patterns of renal conservation of calcium and bone resorption in premenopausal women. Osteoporos Int 12: 43-8.
38. Aloia J, Vaswani A, Yeh J, Flaster E (1996) Risk for osteoporosis in black women. Calcif Tissue Int 59: 415-23.
39. Freedman BI, Register TC (2012) Effect of race and genetics on vitamin D metabolism, bone and vascular health. Nature Review Nephrology 8: 459-466.
40. Wang Y, Hanifi-Moghaddam P, Hanekamp EE, Kloosterboer HJ, Franken P, et al. (2009) Progesterone inhibition of Wnt/beta-catenin signaling in normal endometrium and endometrial cancer. Clinical Cancer Research 15: 5784-5793.
41. Scott EL, Brann DW (2012) Estrogen regulation of Dkk1 and Wnt/b-Catenin signaling in neurodegenerative disease. Brain Research 1514: 63-74.
42. Garcá-Martín A, Rozas-Moreno P, Reyes-Garcá R, Morales-Santana S, Garc?á-Fontana B, et al. (2012) Circulating levels of sclerostin are increased in patients with type 2 diabetes mellitus. Journal of Clinical Endocrinology and Metabolism 97: 234-241.
43. Thambiah S, Roplekar R, Manghat P, Fogelman I, Fraser WD, et al. (2012) Circulating sclerostin and Dickkopf-1 (DKK1) in predialysis chronic kidney disease (CKD): Relationship with bone density and arterial stiffness. Calcified Tissue International 90: 473-480.
44. Kawano Y, Kypta R (2003) Secreted antagonists of the Wnt signalling pathway. J Cell Sci 116: 2627-34.